0001950047-23-001861.txt : 20230622 0001950047-23-001861.hdr.sgml : 20230622 20230622161249 ACCESSION NUMBER: 0001950047-23-001861 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230622 DATE AS OF CHANGE: 20230622 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Entrada Therapeutics, Inc. CENTRAL INDEX KEY: 0001689375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813983399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40969 FILM NUMBER: 231033441 BUSINESS ADDRESS: STREET 1: ONE DESIGN CENTER PLACE STREET 2: SUITE 17-500 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: ONE DESIGN CENTER PLACE STREET 2: SUITE 17-500 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: CycloPorters, Inc. DATE OF NAME CHANGE: 20161104 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Dowden Nathan J CENTRAL INDEX KEY: 0001873392 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 144 1 primary_doc.xml 144 0001873392 XXXXXXXX LIVE 0001689375 ENTRADA THERAPEUTICS INC 001-40969 6 Tide Street Boston MA 02210 8575209158 NATHAN DOWDEN Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

7097 107519.55 33197018 06/22/2023 NASDAQ Common 07/31/2021 Previously Exercised Stock Options Issuer N 7097 07/31/2021 Cash N 10b5-1 Sales Plan for NATHAN DOWDEN

6 Tide Street Boston MA 02210

Common 06/20/2023 8885 132703.78 06/22/2023 03/20/2023 /s/ NATHAN DOWDEN